These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 570843)

  • 1. Effect of anti-P1A1 antibody on human platelets. I. The role of complement.
    Cines DB; Schreiber AD
    Blood; 1979 Apr; 53(4):567-77. PubMed ID: 570843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of anti-P1A1 antibody on human platelets. II. Mechanism of the complement-dependent release reaction.
    Schreiber AD; Cines DB; Zmijewski C; Colman RW
    Blood; 1979 Apr; 53(4):578-87. PubMed ID: 426908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura.
    Tsubakio T; Tani P; Curd JG; McMillan R
    Br J Haematol; 1986 Jun; 63(2):293-300. PubMed ID: 3718872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased fluidity of human platelet membranes during complement-mediated immune platelet injury.
    Shattil SJ; Cines DB; Schreiber AD
    J Clin Invest; 1978 Mar; 61(3):582-9. PubMed ID: 641139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.
    Dixon RH; Rosse WF
    J Clin Invest; 1977 Feb; 59(2):360-8. PubMed ID: 833281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternate complement pathway induction of aggregation and release of 5-hydroxytryptamine and adenosine diphosphate by rabbit platelets.
    Marney SR; Colley DG; Des Prez RM
    J Immunol; 1975 Feb; 114(2 Pt 1):696-703. PubMed ID: 804512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific interaction of HLA antibodies (eluates) with washed platelets.
    Heinrich D; Stephinger U; Mueller-Eckhardt C
    Br J Haematol; 1977 Mar; 35(3):441-52. PubMed ID: 870007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release, aggregation and lysis of human platelets by antilymphocyte globulin and antiplatelet serum.
    Lekas N; Rosenberg JC
    Thromb Haemost; 1976 Nov; 36(2):411-23. PubMed ID: 1087479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of heterologous antibody on human platelets.
    Colman RW; Schreiber AD
    Blood; 1976 Jul; 48(1):119-31. PubMed ID: 947400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactions involving platelets. III. Quantitative aspects of platelet agglutination, inhibition of clot retraction, and other reactions caused by the antibody of quinidine purpura.
    SHULMAN NR
    J Exp Med; 1958 May; 107(5):697-710. PubMed ID: 13525580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of leuCAM integrins and complement in platelet-monocyte rosette formation induced by immune complexes of human immunodeficiency virus-type 1-immune thrombocytopenic purpura patients.
    Hymes K; Nardi M; Leaf A; Karpatkin S
    Blood; 1993 May; 81(9):2375-80. PubMed ID: 8481517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets.
    Rijkers M; Schmidt D; Lu N; Kramer CSM; Heidt S; Mulder A; Porcelijn L; Claas FHJ; Leebeek FWG; Jansen AJG; Jongerius I; Zeerleder SS; Vidarsson G; Voorberg J; de Haas M
    Haematologica; 2019 Feb; 104(2):403-416. PubMed ID: 30262558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human complement system in thrombin-mediated platelet function.
    Polley MJ; Nachman R
    J Exp Med; 1978 Jun; 147(6):1713-26. PubMed ID: 681879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransfusion purpura. Report of a case with anti-P1A1 masked by HLA antibodies.
    Dunstan RA; Rosse WF
    Transfusion; 1985; 25(3):219-22. PubMed ID: 3159134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transfusion purpura: an enigma of alloimmunization.
    Lau P; Sholtis CM; Aster RH
    Am J Hematol; 1980; 9(3):331-6. PubMed ID: 7015849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromium-51 release from human blood platelets by anti A antibody.
    Zakowich P; Morse EE
    Ann Clin Lab Sci; 1975; 5(1):27-30. PubMed ID: 1167441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticomplementary activity of tuberculin: relationship to platelet aggregation and lytic response.
    Rourke FJ; Fan SS; Wilder MS
    Infect Immun; 1979 Jan; 23(1):160-7. PubMed ID: 106002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro histamine and serotonin release by radiographic contrast media (RCM). Complement-dependent and -independent release reaction and changes in ultrastructure of human blood cells.
    Ring J; Arroyave CM; Frizler MJ; Tan EM
    Clin Exp Immunol; 1978 Apr; 32(1):105-18. PubMed ID: 78780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-bound hemagglutinin mediates antibody and complement-dependent lysis of influenza virus-treated human platelets in autologous serum.
    Kazatchkine MD; Lambré CR; Kieffer N; Maillet F; Nurden AT
    J Clin Invest; 1984 Sep; 74(3):976-84. PubMed ID: 6470149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.